RAPS RAC-GS Exam (page: 1)
RAPS Regulatory Affairs Certification (RAC) Global Scope
Updated on: 25-Dec-2025

Viewing Page 1 of 21

A company's product was approved by a regulatory authority with the condition that further studies must be completed prior to full approval of the product.
To minimize product-associated risk to patients during the period of conditional approval, what is the LEAST effective way to achieve this goal?

  1. Label the product for use in appropriate populations.
  2. Educate patients and healthcare providers on how to use the product
  3. Delay product launch until required studies are completed.
  4. Promote off-label use to a carefully selected patient population.

Answer(s): D



A global company is developing a sophisticated implantable medical device that is coated with antibiotics and biologics to enhance its efficacy. The product is marketed in Country X. where it is regulated as a medical device. The same product, without theantibiotics and biologics, is marketed as a medical device in Country Y. The company is proposing to start marketing the coated device in Country Y. Which regulatory approach should the company propose?

  1. Submit the product for review as a pharmaceutical product in Country Y.
  2. Submit the product as a medical device in Country Y as the product is already marketed in Country X as a medical device.
  3. Apply for review of the additional part of the product as a pharmaceutical product in Country
  4. Examine decisions made about similar products in Country Y to propose the classification ofthe product.

Answer(s): C,D



Company X acquires Company Y. Both companies produce pharmaceuticals distributed globally. A regulatory authority requires that all labeling for Company Y's products be
converted to Company X within three months. The regulatory affairs professional at Company X concludes that it is not feasible to meet this request within the time frame.
Which is the FIRST step that the regulatory affairs professional at Company X should take to address the situation?

  1. Develop a plan of action with tasks, timelines, and responsibilities and request an extension period from the regulatory authority.
  2. Request additional resources from senior management in order to complete the labeling conversion within the time frame given by the regulatory authority.
  3. Submit as many labelingconversion applications as possible within the time frame and request an extension for the remaining ones.
  4. Convene an urgent meeting with internal stakeholders to inform them of the regulatory authority requirement and assign responsibilities.

Answer(s): A



A protocol for a pivotal registration trial of a new product is submitted to a major regulatory authority for review and approval. The regulatory authority issues the company a written commitment that if the studies are completed as outlined in the protocol and the results meet the pre-specified criteria for efficacy and safety, the product will be approved.
During the final week of the review of the marketing application, which has fully met all pre- specified criteria, the company receives a letter from the regulatory authority stating that it no longer believes that the product will be approved based on a recent withdrawal of a similar product in another country.
What is the BEST response?

  1. Notify the regulatory authority regarding Its obligation to honor the commitment to approve the application.
  2. Consult with the legal department to discuss the best course of action.
  3. Review the regulatory guidelines to determine how to proceed.
  4. Request a meeting with the regulatory authority to discuss the application.

Answer(s): D



In order to develop a global drug product, what is the MOST important environmental characteristic to consider in the country of intended use?

  1. Product stability
  2. Product registration
  3. Product formulation
  4. Product requirements

Answer(s): A



Viewing Page 1 of 21



Share your comments for RAPS RAC-GS exam with other users:

david 12/12/2023 12:38:00 PM

this was on the exam as of 1211/2023
Anonymous


Tink 7/24/2023 9:23:00 AM

great for prep
GERMANY


Jaro 12/18/2023 3:12:00 PM

i think in question 7 the first answer should be power bi portal (not power bi)
Anonymous


9eagles 4/7/2023 10:04:00 AM

on question 10 and so far 2 wrong answers as evident in the included reference link.
Anonymous


Tai 8/28/2023 5:28:00 AM

wonderful material
SOUTH AFRICA


VoiceofMidnight 12/29/2023 4:48:00 PM

i passed!! ...but barely! got 728, but needed 720 to pass. the exam hit me with labs right out of the gate! then it went to multiple choice. protip: study the labs!
UNITED STATES


A K 8/3/2023 11:56:00 AM

correct answer for question 92 is c -aws shield
Anonymous


Nitin Mindhe 11/27/2023 6:12:00 AM

great !! it is really good
IRELAND


BailleyOne 11/22/2023 1:45:00 AM

explanations for the answers are to the point.
Anonymous


patel 10/25/2023 8:17:00 AM

how can rea next
INDIA


MortonG 10/19/2023 6:32:00 PM

question: 128 d is the wrong answer...should be c
EUROPEAN UNION


Jayant 11/2/2023 3:15:00 AM

thanks for az 700 dumps
Anonymous


Bipul Mishra 12/14/2023 7:12:00 AM

thank you for this tableau dumps . it will helpfull for tableau certification
UNITED STATES


hello 10/31/2023 12:07:00 PM

good content
Anonymous


Matheus 9/3/2023 2:14:00 PM

just testing if the comments are real
UNITED STATES


yenvti2@gmail.com 8/12/2023 7:56:00 PM

very helpful for exam preparation
Anonymous


Miguel 10/5/2023 12:16:00 PM

question 11: https://help.salesforce.com/s/articleview?id=sf.admin_lead_to_patient_setup_overview.htm&type=5
SPAIN


Noushin 11/28/2023 4:52:00 PM

i think the answer to question 42 is b not c
CANADA


susan sandivore 8/28/2023 1:00:00 AM

thanks for the dump
Anonymous


Aderonke 10/31/2023 12:51:00 AM

fantastic assessments
Anonymous


Priscila 7/22/2022 9:59:00 AM

i find the xengine test engine simulator to be more fun than reading from pdf.
GERMANY


suresh 12/16/2023 10:54:00 PM

nice document
Anonymous


Wali 6/4/2023 10:07:00 PM

thank you for making the questions and answers intractive and selectable.
UNITED STATES


Nawaz 7/18/2023 1:10:00 AM

answers are correct?
UNITED STATES


das 6/23/2023 7:57:00 AM

can i belive this dump
INDIA


Sanjay 10/15/2023 1:34:00 PM

great site to practice for sitecore exam
INDIA


jaya 12/17/2023 8:36:00 AM

good for students
UNITED STATES


Bsmaind 8/20/2023 9:23:00 AM

nice practice dumps
Anonymous


kumar 11/15/2023 11:24:00 AM

nokia 4a0-114 dumps
Anonymous


Vetri 10/3/2023 12:59:00 AM

great content and wonderful to have the answers with explanation
UNITED STATES


Ranjith 8/21/2023 3:39:00 PM

for question #118, the answer is option c. the screen shot is showing the drop down, but the answer is marked incorrectly please update . thanks for sharing such nice questions.
Anonymous


Eduardo Ramírez 12/11/2023 9:55:00 PM

the correct answer for the question 29 is d.
Anonymous


Dass 11/2/2023 7:43:00 AM

question no 22: correct answers: bc, 1 per session 1 per page 1 per component always
UNITED STATES


Reddy 12/14/2023 2:42:00 AM

these are pretty useful
Anonymous